ORDER BY 2PM AEST · SHIPS TODAY
FREE EXPRESS OVER $200 · AUSPOST TRACKED
DISPATCHED FROM SYDNEY
BATCH 2026-A1 · 99.8% HPLC VERIFIED
ORDER BY 2PM AEST · SHIPS TODAY
FREE EXPRESS OVER $200 · AUSPOST TRACKED
DISPATCHED FROM SYDNEY
BATCH 2026-A1 · 99.8% HPLC VERIFIED
Back to Shop/RETATRUTIDE
RETATRUTIDE
99.47% HPLC
Batch B-RET-0301-A
HPLC Tested·Cold-Chain·AU Dispatch

Triple-agonist research page

Retatrutide 10mg and 20mg - Research Peptide Australia

Retatrutide (10mg)

Batch·B-RET-0301-A
HPLC·99.47%
Dispatch·Sydney same day

The triple-agonist product page for GLP-1, GIP, and glucagon research comparisons. Choose 10mg or 20mg with batch proof shown before checkout.

GLP-1 / GIP / GlucagonWeeklyAppetite

Choose strength

20mg is $20 more

Before checkout

Label strength: Retatrutide (10mg)
Batch: B-RET-0301-A, HPLC 99.47%
Storage: Lyophilized: 24 months at -20°C | Reconstituted: 21 days at 2-8°C
$149
Secure Checkout
Same-Day Dispatch
30-day cooling-off on eligible unopened items
Clear return policy before checkout
AusPost dispatch from Sydney
Batch COA path before dispatch

Research-grade material for reference and laboratory use only. This page does not provide dosing, administration, or treatment guidance.

Published Research

Eli Lilly, December 2025

TRIUMPH-4 Phase 3 topline results

Reported 28.7% average weight reduction at 68 weeks in the 12mg arm, with knee osteoarthritis endpoints reported in the same release.

New England Journal of Medicine, 2023

Retatrutide for obesity

Phase 2 clinical paper describing the GLP-1, GIP, and glucagon triple-agonist mechanism.

Evidence balance

Safety signal to read first: Lilly reported dysesthesia at higher Phase 3 doses and higher adverse-event discontinuation than placebo. The Phase 2 paper also reports dose-dependent heart-rate changes, so this is not a casual add-to-cart product.

Batch and handling

Triple-agonist record: GLP-1, GIP, and glucagon in one weekly product route.

Targets three metabolic receptors at once, with 10mg and 20mg strength options.

Check HPLC purity, batch ID, storage, solvent, dispatch path, and COA before checkout.

Resources

Resource

Batch verification

See how purity, release, and batch records are surfaced on-site.

Resource

Retatrutide buying guide

The comparison route buyers use before choosing a supplier.

Resource

Supplier standards

Useful if the trust layer matters more than hype or branding.

Retatrutide

The weekly step-up.

The visual gives the buyer the why. The batch record gives them the reason to trust this vial.

Loose clothing fit check used for Retatrutide body-composition context

When the usual plan stalls

The weekly step-up buyers compare when they want the strongest body-composition option in the range.

Waist tape measurement used for Retatrutide body-composition context

Proof before promise

Batch ID, HPLC percentage, storage, and dispatch stay visible. If those are missing, the story does not matter.

Trust. Testing. Transparency.

Questions We Get Asked

These are the checks buyers make before they trust the product record: batch, storage, dispatch, and support route.

Retatrutide is a triple agonist: GLP-1, GIP, and glucagon receptors. Semaglutide is GLP-1 only. Tirzepatide is GLP-1 plus GIP. Researchers compare Retatrutide when they want the heavier triple-pathway literature. Phase 2 data was published in NEJM in 2023.

Need a straight answer before you order?

Browse All Products